Document KRDjgyEjZVazLQJedn1w62er0
: FP
CC: oS. C.croft
54a99 20;ne
- 255
Sa
CONFIDENTIAL
LB.. JW.. PCauplapepper -- 2N5-611400 PRAL File - 256
E. I. bu Pont o Nemours & Company
12.
=a
WILMINGTON, DELAWARE 19898
42264-1628
ePD
September 21, 1983
PERSONAL CONFIDENTIAL
OERN.GIN0.EERP.INTGEDDEESPCAORTMENT T1E16 LOWIERS BUILDING
sf
SEPaa IE
xEenD. cSTaATInON
T8UE31No. -AN1AL0YSI4SPOR6FALB,NLoOOsD.8S3A-MP4L8E4S8-F4O8R49P;ENRoFtLeUbOoRoOkOCTNAoNsO.ATE27433, 29324, 29325)
submitted fAsromreTqruaelseteedPairnkyo(uFrAFPl)etetmeprlooyfee9s/1h4a/8v3e,betehne atnwaolybzleododfosramppleersfluorosoacmtpalneoatieden(tCgi)ficbyatitohne aurseualgivgeans icnhrotmheataotgtraacphheidc mteabtlheo.d ES-567. Results and
AtStLa:ckha.b Key Words
Pe6rfluorooctanoate Blood Analysis
RR
Sharron Laas
+ 2 =gs
00023
aren fume Annee on
USEPA 10528
TaBLE 1 CONCENTRATION OF PERFLUOROOCTANOATEINBLOOD (2)
CONFIDENTIAL
Ser e rr oe or
83-4848
-
-
83-4849 -
-
CBiematsmatAyT eFeds
9/16/83
0.17
916/83
0.15
(3) Analysis as described in Lab Method ES-567 ("Deternination of Perfluoraoctanolc 25
ApcaicdkedincoBllouozdn,GGCasanCalhyrsoimsatvoigtrahphpiecrflMeutohrood-"n,-ocSt.anSotlacffoarcdi,d 4as/3/c8a1l)i,bruatsiionng stthaendard. g3
(8) cAlotnhcoeungthrattihoensanaarleysgisivetns isnpepcpisficfalluloyrinfeorfoprerfcloumopraoroicsotnanwciatthe t(haecidreosrultsseltosf),
Etsottialmatoerdganuinccerftlauionrtiyne4asn+aly1s0e2s.rela(t5ipvmeFs=ta0nd.a6r8d8 xdevpipamtipoenr.fluoTrhoeocltoavneoricliamcitid)
c<foonr0c.e0q0nu7ta.rnattiitKoaotnniseondinetisetch0att.e0d0r7a(nnpg.ged.F)/cga.n1snotreTphboeercwdeeedltlecfoqtruiaonnstaimltpialmteiestdviisatn*hd
0a.r0e04rewpgoFr/tge,d [Cg] 0.004
basut ppa.
which cannot be distinguished from reagent background.
>
7 000227
USEPA 10529